共 269 条
[1]
Das S(2019)Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors J Immunother Cancer 7 306-e1103
[2]
Johnson DB(2019)Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies Neurology 93 e1093-775
[3]
Dubey D(2022)Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies Cancer Immunol Immunother 71 769-688
[4]
David WS(2021)Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature J Neurol 268 680-669
[5]
Amato AA(2021)Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors J Immunother Cancer 9 e002890-674
[6]
Reynolds KL(2020)Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum Ann Neurol 87 659-e202
[7]
Clement NF(2019)Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies: systematic review Neurology 92 663-766
[8]
Chute DF(2021)Autoimmune encephalitis related to cancer treatment with immune checkpoint inhibitors: a systematic review Neurology 97 e191-436
[9]
Cohen JV(2021)Neurologic adverse events of immune checkpoint inhibitors: a systematic review Neurology 96 754-288
[10]
Lawrence DP(2019)Autonomic disorders Am J Med 132 420-758